These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8450401

  • 1. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
    Fischl MA, Krown SE, O'Boyle KP, Mitsuyasu R, Miles S, Wernz JC, Volberding PA, Kahn J, Groopman JE, Feinberg J.
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):259-64. PubMed ID: 8450401
    [Abstract] [Full Text] [Related]

  • 2. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM.
    AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M.
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [Abstract] [Full Text] [Related]

  • 6. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M, Tomlinson D, Stewart S.
    J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA.
    Cancer J Sci Am; 1997 Apr; 3(5):278-83. PubMed ID: 9327151
    [Abstract] [Full Text] [Related]

  • 10. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM.
    Leukemia; 1994 Apr; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD, Goldstein D, Goos M, Jablonowski H, Stewart JS.
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [Abstract] [Full Text] [Related]

  • 12. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G, Sprinz E, Kromfield M, Kalakun L, Sander E, Prolla G, Di Leone L, Gerhardt L, Mans DR.
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [Abstract] [Full Text] [Related]

  • 13. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Hengge UR, Brockmeyer NH, Baumann M, Reimann G, Goos M.
    Lancet; 1993 Aug 21; 342(8869):497. PubMed ID: 8102452
    [No Abstract] [Full Text] [Related]

  • 14. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug 21; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan 21; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 16. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
    James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS.
    Clin Oncol (R Coll Radiol); 1994 Jan 21; 6(5):294-6. PubMed ID: 7530036
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A, Coronado O, Cancellieri C, Manfredi R, Pignatari S, Chiodo F.
    J Chemother; 1998 Oct 21; 10(5):405-10. PubMed ID: 9822360
    [Abstract] [Full Text] [Related]

  • 18. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy.
    Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, Levine AM.
    Cancer; 1990 Mar 01; 65(5):1074-8. PubMed ID: 1689209
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA, Forrest A, Northfelt DW, Mamelok R.
    Clin Pharmacol Ther; 1997 Mar 01; 61(3):301-11. PubMed ID: 9084455
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME, Lachter J, Spencer D, Bezwoda WR.
    Int J Dermatol; 1995 Oct 01; 34(10):729-32. PubMed ID: 8537166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.